Related Experiment Video
Updated: Sep 28, 2025
Metagenomic Analysis of Silage
Published on: January 13, 2017
Pneumocystis Jirovecii Pneumonia Diagnosis via Metagenomic Next-Generation Sequencing
Xiaoxiao Lu1, Jianhui Zhang1,2, Wentao Ma1
1Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.
Abstract:
The incidence of non-HIV-infected Pneumocystis Jirovecii Pneumonia (PJP) is increasing. The prognosis for non-HIV PJP is poor and diagnostic tests are of lower sensitivity in non-HIV patients. Metagenomic next-generation sequencing (mNGS) was compared with routine detection assays, including Gomori methenamine silver (GMS) stain and polymerase chain reaction (PCR) technique. Specimens of 4 bronchoalveolar lavages (BAL) and 1 lung tissue samples were obtained from 4 non-HIV patients from our hospitals. Although both GMS and mNGS were positive for P. jirovecii with PCR as positive control, the testing time of mNGS was obviously shorter than GMS. Compared with the traditional GMS method, mNGS has absolute advantages. However, the issue with PJP presentations having atypical symptoms and ambiguous imaging features persists. Hence, the disease can easily be ignored. Secondly, PJP progresses rapidly in non-HIV-infected patients and can cause severe respiratory failure with unfavorable prognosis. This study affirms that mNGS can be used to quickly and accurately diagnose PJP, but a combination of clinical judgement of symptoms, laboratory testing, and imaging examination is required to make a comprehensive judgment along with mNGS test results.
Insights
Metagenomic next-generation sequencing (mNGS) offers a faster and accurate diagnosis for Pneumocystis Jirovecii Pneumonia (PJP) in non-HIV patients. Combining mNGS with clinical evaluation improves diagnostic certainty for this increasing, severe condition.
Area of Science:
- Medical Diagnostics
- Infectious Diseases
- Molecular Biology
Background:
- Non-HIV Pneumocystis Jirovecii Pneumonia (PJP) incidence is rising, presenting poor prognoses and diagnostic challenges.
- Traditional diagnostic tests for PJP in non-HIV patients often exhibit lower sensitivity.
- Atypical presentations and ambiguous imaging in non-HIV PJP can lead to delayed diagnosis and rapid progression.
Purpose of the Study:
- To compare the diagnostic performance of metagenomic next-generation sequencing (mNGS) against routine assays for non-HIV PJP.
- To evaluate the turnaround time and accuracy of mNGS for PJP detection.
- To highlight the clinical utility of mNGS in managing non-HIV PJP.
Main Methods:
- Retrospective analysis of 4 non-HIV patients with suspected PJP.
- Comparison of mNGS with Gomori methenamine silver (GMS) stain and polymerase chain reaction (PCR).
- Analysis of bronchoalveolar lavage (BAL) and lung tissue samples.
Main Results:
- mNGS and GMS both detected *P. jirovecii*, with PCR as a positive control.
- mNGS demonstrated a significantly shorter testing time compared to GMS.
- mNGS offers advantages over traditional methods for PJP diagnosis.
Conclusions:
- mNGS is a rapid and accurate tool for diagnosing PJP in non-HIV individuals.
- Clinical judgment, laboratory tests, and imaging remain crucial alongside mNGS results.
- Comprehensive evaluation is necessary for effective management of non-HIV PJP.
Related Concept Videos
03:00Next-generation Sequencing
Next-Generation Sequencing Methods
Although all next-generation methods use different technologies, they all share a set of standard features....
01:29Modern Molecular Taxonomy